Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation

Molecular and Cellular Biology

Volumn 33, Issue 10, 2013, Pages 1901-1915

  Blackwell, Ken ^a   Zhang, Laiqun ^a   Workman, Lauren M ^b   Ting, Adrian T ^c   Iwai, Kazuhiro ^d   Habelhah, Hasem ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; RECEPTOR INTERACTING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; RALBP1 PROTEIN, MOUSE; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; UBIQUITINATION; ANIMAL; CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INACTIVATION; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GTPASE-ACTIVATING PROTEINS; HEPATOCYTES; HUMANS; I-KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEINS; MICE; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEOLYSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION;

MLCS; MLOWN;

EID: 84878376898     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01416-12     Document Type: Article

References (46)

1. Hayden MS, Ghosh S. 2008. Shared principles in NF-kappaB signaling. Cell 132:344-362.
2. Wajant H, Scheurich P. 2011. TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J. 278:862-876.
3. Vallabhapurapu S, Karin M. 2009. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol. 27:693-733.
4. Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, Banerjee A. 2006. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25:6781-6799.
5. Chen ZJ, Sun LJ. 2009. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33:275-286.
6. Wong WW, Gentle IE, Nachbur U, Anderton H, Vaux DL, Silke J. 2010. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ. 17:482-487.
7. Xu M, Skaug B, Zeng W, Chen ZJ. 2009. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol. Cell 36:302-314.
8. Zhang L, Blackwell K, Thomas GS, Sun S, Yeh WC, Habelhah H. 2009. TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells. J. Mol. Biol. 389:495-510.
9. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. 2006. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat. Cell Biol. 8:398-406.
10. Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J, Korneluk RG. 2008. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 105:11778-11783.
11. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, Vucic D. 2008. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFα)-induced NF-κB activation. J. Biol. Chem. 283:24295-24299.
12. Yin Q, Lamothe B, Darnay BG, Wu H. 2009. Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry 48:10558-10567.
13. Vince JE, Pantaki D, Feltham R, Mace PD, Cordier SM, Schmukle AC, Davidson AJ, Callus BA, Wong WW, Gentle IE, Carter H, Lee EF, Walczak H, Day CL, Vaux DL, Silke J. 2009. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate nf-{kappa}b and to prevent TNF-induced apoptosis. J. Biol. Chem. 284:35906-35915.
14. Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T, Milstien S, Spiegel S. 2010. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465:1084-1088.
15. Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh WC, Nakano H. 2001. Critical roles of TRAF2 and TRAF5 in tumor necrosis factorinduced NF-kappa B activation and protection from cell death. J. Biol. Chem. 276:36530-36534.
16. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. 1998. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8:297-303.
17. Ting AT, Pimentel-Muinos FX, Seed B. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1- initiated apoptosis. EMBO J. 15:6189-6196.18. Feltham R, Moulin M, Vince JE, Mace PD, Wong WW, Anderton H, Day CL, Vaux DL, Silke J. 2010. Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J. Biol. Chem. 285:17525-17536.
18. Feltham R, Moulin M, Vince JE, Mace PD, Wong WW, Anderton H, Day CL, Vaux DL, Silke J. 2010. Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J. Biol. Chem. 285:17525-17536.
19. Moulin M, Anderton H, Voss AK, Thomas T, Wong WW, Bankovacki A, Feltham R, Chau D, Cook WD, Silke J, Vaux DL. 2012. IAPs limit activation of RIP kinases by TNF receptor 1 during development.EMBOJ. 31:1679-1691.
20. Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, Ronai Z. 2004. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J. 23:322-332.
21. Yamamoto M, Okamoto T, Takeda K, Sato S, Sanjo H, Uematsu S, Saitoh T, Yamamoto N, Sakurai H, Ishii KJ, Yamaoka S, Kawai T, Matsuura Y, Takeuchi O, Akira S. 2006. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7:962-970.
22. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, Helgason E, Fairbrother WJ, Deshayes K, Kirkpatrick DS, Vucic D. 2010. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29:4198-4209.
23. Iwai K, Tokunaga F. 2009. Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Rep. 10:706-713.
24. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T, Koschny R, Komander D, Silke J, Walczak H. 2009. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36:831-844.
25. Zhang L, Blackwell K, Shi Z, Habelhah H. 2010. The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. J. Mol. Biol. 396:528-539.
26. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, Yamamoto M, Akira S, Takao T, Tanaka K, Iwai K. 2009. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 11:123-132.
27. Blackwell K, Zhang L, Thomas GS, Sun S, Nakano H, Habelhah H. 2009. TRAF2 phosphorylation modulates tumor necrosis factor alphainduced gene expression and cell resistance to apoptosis. Mol. Cell. Biol. 29:303-314.
28. Wajant H, Henkler F, Scheurich P. 2001. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13:389-400.
29. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. U. S. A. 88:2830-2834.
30. Gentle IE, Wong WW, Evans JM, Bankovacki A, Cook WD, Khan NR, Nachbur U, Rickard J, Anderton H, Moulin M, Lluis JM, Moujalled DM, Silke J, Vaux DL. 2011. In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. J. Biol. Chem. 286: 13282-13291.
31. Joazeiro CA, Weissman AM. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549-552.
32. Wang L, Du F, Wang X. 2008. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133:693-703.
33. Feldmann M, Maini RN. 2003. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9:1245-1250.
34. Schmukle AC, Walczak H. 2012. No one can whistle a symphony alone: how different ubiquitin linkages cooperate to orchestrate NF-kappaB activity. J. Cell Sci. 125:549-559.
35. Hoffmann A, Levchenko A, Scott ML, Baltimore D. 2002. The IkappaBNF- kappaB signaling module: temporal control and selective gene activation. Science 298:1241-1245.
36. Okazaki T, Sakon S, Sasazuki T, Sakurai H, Doi T, Yagita H, Okumura K, Nakano H. 2003. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300:807-812.
37. Hoffmann A, Leung TH, Baltimore D. 2003. Genetic analysis of NFkappaB/ Rel transcription factors defines functional specificities. EMBO J. 22:5530-5539.
38. Saccani S, Pantano S, Natoli G. 2001. Two waves of nuclear factor kappaB recruitment to target promoters. J. Exp. Med. 193:1351-1359.
39. Zarnegar B, Yamazaki S, He JQ, Cheng G. 2008. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 105:3503-3508.
40. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H, Wong WW, Nachbur U, Gangoda L, Warnken U, Purcell AW, Silke J, Walczak H. 2011. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471:591-596.
41. Bertrand MJ, Lippens S, Staes A, Gilbert B, Roelandt R, De Medts J, Gevaert K, Declercq W, Vandenabeele P. 2011. cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). PLoS One 6:e22356. doi:10.1371 /journal.pone.0022356.
42. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. 2006. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22:245-257.
43. Kulathu Y, Akutsu M, Bremm A, Hofmann K, Komander D. 2009. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nat. Struct. Mol. Biol. 16:1328-1330.
44. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D, Randow F, Wakatsuki S, Dikic I. 2009. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136:1098-1109.
45. Komander D, Clague MJ, Urbe S. 2009. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10:550-563.
46. Hostager BS, Kashiwada M, Colgan JD, Rothman PB. 2011. HOIL-1L interacting protein (HOIP) is essential for CD40 signaling. PLoS One 6:e23061. doi:10.1371/journal.pone.0023061.